Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 3
2008 2
2009 3
2010 1
2011 1
2012 1
2013 2
2014 2
2015 1
2016 3
2017 2
2018 1
2019 2
2020 3
2021 6
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
Long-term sexual functioning in germ-cell tumor survivors.
Chovanec M, Vasilkova L, Petrikova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Mladosievicova B, Mardiak J, Mego M. Chovanec M, et al. Among authors: obertova j. BMC Cancer. 2020 Aug 20;20(1):779. doi: 10.1186/s12885-020-07301-6. BMC Cancer. 2020. PMID: 32819309 Free PMC article.
Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.
Chovanec M, Vasilkova L, Setteyova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Cingelova S, Mladosievicova B, Mardiak J, Mego M. Chovanec M, et al. Among authors: obertova j. Oncologist. 2018 May;23(5):617-623. doi: 10.1634/theoncologist.2017-0457. Epub 2018 Jan 19. Oncologist. 2018. PMID: 29352051 Free PMC article.
Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
Kalavska K, Sestakova Z, Mlcakova A, Kozics K, Gronesova P, Hurbanova L, Miskovska V, Rejlekova K, Svetlovska D, Sycova-Mila Z, Obertova J, Palacka P, Mardiak J, Chovanec M, Chovanec M, Mego M. Kalavska K, et al. Among authors: obertova j. Int J Mol Sci. 2021 Jul 31;22(15):8281. doi: 10.3390/ijms22158281. Int J Mol Sci. 2021. PMID: 34361047 Free PMC article.
Survival Prediction by Baseline Systemic Immune-inflammation Index (SII) and its Changes During First-line Platinum-based Treatment in a Caucasian Population of Patients With Metastatic Urothelial Carcinoma (MUC).
Palacka P, Slopovsky J, Obertova J, Chovanec M, Rejlekova K, Sycova-Mila Z, Kollarik B, Mardiak J, Mego M. Palacka P, et al. Among authors: obertova j. Anticancer Res. 2021 Nov;41(11):5749-5759. doi: 10.21873/anticanres.15391. Anticancer Res. 2021. PMID: 34732448
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.
Mego M, Rejlekova K, Svetlovska D, Miskovska V, Gillis AJM, De Angelis V, Kalavska K, Obertova J, Palacka P, Reckova M, Sycova-Mila Z, Pindak D, Chovanec M, Looijenga LHJ, Mardiak J. Mego M, et al. Among authors: obertova j. Eur Urol Open Sci. 2021 Sep 22;33:19-27. doi: 10.1016/j.euros.2021.09.002. eCollection 2021 Nov. Eur Urol Open Sci. 2021. PMID: 34738090 Free PMC article.
DNA damage measured in blood cells predicts overall and progression-free survival in germ cell tumour patients.
Sestakova Z, Kalavska K, Smolkova B, Miskovska V, Rejlekova K, Sycova-Mila Z, Palacka P, Obertova J, Holickova A, Hurbanova L, Jurkovicova D, Roska J, Goffa E, Svetlovska D, Chovanec M, Mardiak J, Mego M, Chovanec M. Sestakova Z, et al. Among authors: obertova j. Mutat Res Genet Toxicol Environ Mutagen. 2020 Jun-Jul;854-855:503200. doi: 10.1016/j.mrgentox.2020.503200. Epub 2020 May 23. Mutat Res Genet Toxicol Environ Mutagen. 2020. PMID: 32660824
PARP expression in germ cell tumours.
Mego M, Cierna Z, Svetlovska D, Macak D, Machalekova K, Miskovska V, Chovanec M, Usakova V, Obertova J, Babal P, Mardiak J. Mego M, et al. Among authors: obertova j. J Clin Pathol. 2013 Jul;66(7):607-12. doi: 10.1136/jclinpath-2012-201088. Epub 2013 Mar 13. J Clin Pathol. 2013. PMID: 23486608
37 results